Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities.
Gut is an official journal of the British Society of Gastroenterology.
Gut publishes podcasts discussing highlights from its issues. Discover them here.
Editor-in-Chief: Professor Emad El-Omar, University of New South Wales, Sydney, Australia
TOP CITED ARTICLES
To celebrate the latest impact factor of 17.016 we have made the most-cited articles from the past three years free to access. See the list here.
FRONTLINE GASTROENTEROLOGY CALL FOR EDITORS
Would you like to join the team behind FG and help to shape it for the future?
The journal is looking for two new associate editors and a trainee associate editor. Click here for more details. The deadline for applications is 10th October 2018.
Read the article: linkTo cite: Cook MB, Coburn SB, Lam JR, et al. Gut 2018;67:418-529.
Objective: Barrett's oesophagus (BE) increases the risk of oesophageal adenocarcinoma by 10–55 times that of the general population, but no community-based cancer-specific incidence and cause-specific mortality risk estimates exist for large cohorts in the USA.
Conclusions: Patients with BE had a persistent excess risk of oesophageal adenocarcinoma over time, although their absolute excess risks for this cancer, any cancer and overall mortality were modest.